| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |